Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Clearside Biomedical Adds Board Member

This article was originally published in Scrip

Executive Summary

Clearside Biomedical Inc., a company focused on therapies for blinding diseases of the eye, has appointed Richard J. Croarkin to its board of directors. Previously, Croarkin was chief financial officer (CFO) of Nestlé Health Science S.A. and served as senior vice president of finance, chief financial officer and corporate strategy officer at Alcon, Inc. Prior to Alcon, he was executive vice president and CFO of Nestlé Waters North America and before this, he held various global senior financial positions at Pepsico Inc.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst